Fulcrum Therapeutics to Present at the Stifel 2019 Healthcare Conference
November 13 2019 - 8:01AM
Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a
clinical-stage biopharmaceutical company focused on improving the
lives of patients with genetically defined rare diseases, today
announced that members of the management team will provide a
business overview and update at the Stifel 2019 Healthcare
Conference at 8:00 a.m. ET on Wednesday, November 20, 2019 in New
York, NY.
A live webcast of the presentation will be available through the
investor relations section of the Company's website at
https://ir.fulcrumtx.com/events-and-presentations. Following the
live webcast, an archived replay will also be available.
About Fulcrum Therapeutics Fulcrum Therapeutics
is a clinical-stage biopharmaceutical company focused on improving
the lives of patients with genetically defined rare diseases in
areas of high unmet medical need. Fulcrum’s proprietary product
engine identifies drug targets which can modulate gene expression
to treat the known root cause of gene mis-expression. Please visit
www.fulcrumtx.com.
Investor Contact:Christina Tartaglia Stern
Investor Relations, Inc. christina@sternir.com212-362-1200
Media Contact: Lynn GranitoBerry & Company
Public Relationslgranito@berrypr.com212-253-8881
Fulcrum Therapeutics (NASDAQ:FULC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Fulcrum Therapeutics (NASDAQ:FULC)
Historical Stock Chart
From Apr 2023 to Apr 2024